Exlites Holdings International, Inc. (EXHI)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Exlites Holdings International, Inc. (EXHI). Exlites Holdings International, Inc. operates in the consumer healthcare and durable medical supply sectors. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Exlites Holdings International, Inc. (EXHI) Healthcare & Pipeline Overview
Exlites Holdings International, Inc. participates in the consumer healthcare and durable medical supply markets, offering consumer products and contract manufacturing services. With a negative profit margin of -32.2% and a high beta of 2.29, the company distributes its products through diverse channels, including catalogs, retailers, and direct consumer venues.
Investment Thesis
Exlites Holdings International, Inc. presents a challenging investment case due to its negative profitability and OTC market listing. With a market capitalization of $0.02 billion and a negative P/E ratio of -631.18, the company's financial performance raises concerns. The high beta of 2.29 indicates significant volatility compared to the broader market. Growth catalysts depend on successful expansion in the consumer healthcare market and efficient contract manufacturing operations. The company's ability to improve its profit margin and manage its operational costs will be critical for future value creation. Investors should carefully consider the risks associated with OTC-listed companies and the company's financial performance before making any investment decisions.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.02 billion reflects its small size within the healthcare sector.
- P/E Ratio of -631.18 indicates the company is currently not profitable.
- Profit Margin of -32.2% suggests significant challenges in achieving profitability.
- Beta of 2.29 indicates higher volatility compared to the market average.
- No Dividend Yield reflects the company's current focus on reinvesting earnings.
Competitors & Peers
Strengths
- Established presence in the market since 1979.
- Diverse product portfolio including consumer and medical supplies.
- Multiple distribution channels.
- Contract manufacturing capabilities.
Weaknesses
- Negative profit margin.
- High beta indicating volatility.
- Small market capitalization.
- OTC market listing.
Catalysts
- Upcoming: Potential new product launches in the consumer healthcare segment.
- Ongoing: Expansion of contract manufacturing agreements with healthcare providers.
- Ongoing: Increased focus on direct-to-consumer sales through online channels.
Risks
- Potential: Intense competition in the healthcare market affecting market share.
- Potential: Regulatory changes impacting medical device manufacturing and distribution.
- Ongoing: Negative profit margin and high operational costs.
- Ongoing: OTC market listing and associated risks.
Growth Opportunities
- Expansion of Consumer Product Line: Exlites Holdings International, Inc. can grow by expanding its consumer product line to include innovative healthcare solutions. The global consumer healthcare market is projected to reach $600 billion by 2028, offering a significant opportunity for growth. The company can focus on developing products that cater to specific consumer needs, such as wearable health devices and home healthcare solutions. Timeline: 2-3 years.
- Increased Contract Manufacturing: The company can increase its revenue by expanding its contract manufacturing business. The global medical device contract manufacturing market is expected to reach $120 billion by 2027. Exlites Holdings International, Inc. can leverage its manufacturing capabilities to secure contracts with hospitals, nursing homes, and assisted living facilities. Timeline: 1-2 years.
- Direct-to-Consumer Sales: Exlites Holdings International, Inc. can enhance its distribution by focusing on direct-to-consumer sales through online channels. The e-commerce healthcare market is growing rapidly, providing a direct avenue to reach consumers. By establishing a strong online presence, the company can reduce its reliance on traditional distribution channels and improve its profit margins. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic partnerships with healthcare providers and distributors can provide Exlites Holdings International, Inc. with access to new markets and customers. Collaborations can lead to the development of new products and services, as well as enhanced distribution capabilities. The company can seek partnerships with established players in the healthcare industry to expand its reach. Timeline: 1-2 years.
- Geographic Expansion: Exlites Holdings International, Inc. can explore opportunities for geographic expansion, particularly in emerging markets with growing healthcare needs. The global healthcare market is expanding rapidly in countries such as China and India, offering significant potential for growth. The company can adapt its products and services to meet the specific needs of these markets. Timeline: 3-5 years.
Opportunities
- Expansion of consumer product line.
- Increased contract manufacturing opportunities.
- Direct-to-consumer sales growth.
- Strategic partnerships with healthcare providers.
Threats
- Intense competition in the healthcare market.
- Regulatory changes affecting medical device manufacturing.
- Economic downturn impacting consumer spending.
- Supply chain disruptions.
Competitive Advantages
- Established presence in the consumer healthcare market since 1979.
- Contract manufacturing capabilities for medical supplies.
- Diverse distribution network including catalogs, retailers, and direct-to-consumer channels.
- Proprietary consumer product designs, such as heated steering wheels and shoe insoles.
About EXHI
Founded in 1979 and headquartered in Salt Lake City, Utah, Exlites Holdings International, Inc. operates within the consumer healthcare and durable medical supply sectors. The company's business is divided into two primary areas: consumer products and contract manufacturing. Its consumer product line includes items such as battery-operated heated steering wheel products, electronic hot and cold packs, and spring-loaded shoe insoles. These products target individual consumers seeking comfort and convenience. In addition to consumer goods, Exlites Holdings International, Inc. engages in the contract manufacturing of medical supplies and devices. These manufactured products are supplied to hospitals, nursing homes, assisted living facilities, and individual consumers. The company distributes its products through a variety of channels, including consumer and medical distributors, catalogs, retailers, and direct-to-consumer venues. The company's diverse distribution network allows it to reach a broad customer base. Despite its long history, Exlites Holdings International, Inc. faces challenges, as reflected in its negative profit margin of -32.2% and a high beta of 2.29.
What They Do
- Engages in the consumer healthcare market.
- Operates in the durable medical supply business.
- Offers battery-operated heated steering wheel products.
- Provides electronic hot and cold packs.
- Manufactures spring-loaded shoe insoles.
- Involved in contract manufacturing of medical supplies and devices.
- Supplies hospitals, nursing homes, and assisted living facilities.
- Distributes products through catalogs and retailers.
Business Model
- Sells consumer healthcare products directly to consumers.
- Generates revenue through contract manufacturing of medical supplies.
- Distributes products through catalogs, retailers, and online channels.
- Partners with medical distributors to reach healthcare providers.
Industry Context
Exlites Holdings International, Inc. operates in the medical distribution industry, which is characterized by increasing demand for durable medical equipment and consumer healthcare products. The market is competitive, with companies like AHGIF (Amikaa Holding Corp), BMKDF (BioMark Diagnostics Inc), CNTMF (Care Net Medical Group Inc), DGNOF (Diagnomics Inc), and ELXMF (Electromed Inc) vying for market share. Trends include a growing aging population, increasing prevalence of chronic diseases, and technological advancements in medical devices. The company's success depends on its ability to differentiate its products, manage costs effectively, and navigate regulatory requirements.
Key Customers
- Individual consumers seeking healthcare products.
- Hospitals and nursing homes requiring medical supplies.
- Assisted living facilities needing durable medical equipment.
- Medical distributors and retailers.
Financials
Chart & Info
Exlites Holdings International, Inc. (EXHI) stock price: Price data unavailable
Latest News
No recent news available for EXHI.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EXHI.
Price Targets
Wall Street price target analysis for EXHI.
MoonshotScore
What does this score mean?
The MoonshotScore rates EXHI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Mark Julian
CEO
Mark Julian serves as the CEO of Exlites Holdings International, Inc. His background includes experience in the consumer healthcare and medical supply industries. He has held various leadership positions in sales and marketing, focusing on product development and distribution strategies. Julian's expertise lies in identifying market opportunities and driving revenue growth through innovative product offerings and strategic partnerships. He is responsible for overseeing the company's operations and executing its growth strategy.
Track Record: Under Mark Julian's leadership, Exlites Holdings International, Inc. has focused on expanding its consumer product line and strengthening its contract manufacturing capabilities. Key milestones include the introduction of new consumer healthcare products and the establishment of partnerships with medical distributors. However, the company's financial performance remains a challenge, with ongoing efforts to improve profitability and manage operational costs.
EXHI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Exlites Holdings International, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier are often subject to less stringent regulations and may have limited financial information available to the public. This can result in increased risk and uncertainty for investors compared to companies listed on major exchanges like the NYSE or NASDAQ. The OTC Other tier is often populated by shell companies, bankrupt entities, or companies with regulatory issues.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: Lack of comprehensive and timely financial reporting increases investment risk.
- Low Liquidity: Difficulty in buying or selling shares due to low trading volume.
- Price Volatility: Higher price fluctuations due to limited market participation.
- Regulatory Scrutiny: Potential for regulatory actions due to non-compliance with disclosure requirements.
- Going Concern Risk: Uncertainty about the company's ability to continue operations.
- Verify the company's financial statements and audit reports.
- Assess the company's management team and their track record.
- Review the company's business plan and growth strategy.
- Evaluate the company's competitive position in the market.
- Check for any legal or regulatory issues.
- Monitor the company's trading volume and price activity.
- Consult with a financial advisor before investing.
- Established presence in the market since 1979.
- Diverse product portfolio including consumer and medical supplies.
- Contract manufacturing capabilities for medical supplies.
- CEO with experience in the healthcare industry.
EXHI Healthcare Stock FAQ
What does Exlites Holdings International, Inc. do?
Exlites Holdings International, Inc. operates in the healthcare sector, focusing on consumer healthcare products and durable medical supplies. The company manufactures and distributes a range of consumer products, including heated steering wheels and shoe insoles, as well as providing contract manufacturing services for medical supplies and devices. These manufactured products are supplied to hospitals, nursing homes, assisted living facilities, and individual consumers. The company distributes its products through various channels, including catalogs, retailers, and direct-to-consumer venues. The company's diverse distribution network allows it to reach a broad customer base.
What do analysts say about EXHI stock?
As of 2026-03-17, there is no readily available analyst coverage for Exlites Holdings International, Inc. (EXHI) due to its OTC listing and small market capitalization. Key valuation metrics such as P/E ratio (-631.18) and profit margin (-32.2%) indicate financial challenges. Investors should conduct their own thorough due diligence, considering the company's growth opportunities and the risks associated with OTC-listed companies before making any investment decisions. The high beta of 2.29 suggests higher volatility compared to the market average.
What are the main risks for EXHI?
Exlites Holdings International, Inc. faces several risks, including intense competition in the healthcare market, regulatory changes affecting medical device manufacturing, and economic downturns impacting consumer spending. The company's negative profit margin and high operational costs pose significant challenges. Additionally, its OTC market listing introduces risks such as limited financial disclosure, low liquidity, and price volatility. Investors should carefully consider these factors before investing in EXHI.
What are the key factors to evaluate for EXHI?
Evaluating EXHI involves reviewing fundamentals, analyst consensus, and risk factors. Key strength: Established presence in the market since 1979.. Primary risk to monitor: Potential: Intense competition in the healthcare market affecting market share.. This is not financial advice.
How frequently does EXHI data refresh on this page?
EXHI prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven EXHI's recent stock price performance?
Recent price movement in Exlites Holdings International, Inc. (EXHI) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established presence in the market since 1979.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider EXHI overvalued or undervalued right now?
Determining whether Exlites Holdings International, Inc. (EXHI) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying EXHI?
Before investing in Exlites Holdings International, Inc. (EXHI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for OTC-listed companies.
- Financial data based on available reports as of 2026-03-17.